Curcumin protects against concanavalin a-induced hepatitis in mice through inhibiting the cytoplasmic translocation and expression of high mobility group Box 1

Inflammation

Volumn 36, Issue 1, 2013, Pages 206-215

  Tu, Chuan Tao ^a   Yao, Qun Yan ^a   Xu, Bei Li ^a   Zhang, Shun Cai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

concanavalin A (ConA); curcumin; hepatitis; high mobility group box 1; inflammation

Indexed keywords

CONCANAVALIN A; CURCUMIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; HEPATITIS; LIVER CELL; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONCANAVALIN A; CURCUMIN; HEPATITIS; HMGB1 PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED BALB C; PROTEIN TRANSPORT; RNA, MESSENGER; TRANSAMINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872965773     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9536-4     Document Type: Article

References (35)

1. Bozza, M., J.L. Bliss, R. Maylor, J. Erickson, L. Donnelly, P. Bouchard, A.J. Dorner, and W.L. Trepicchio. 1999. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30: 1441-1447.
2. Nunnari, G., and M.J. Schnell. 2011. MicroRNA-122: A therapeutic target for hepatitis C virus (HCV) infection. Frontiers in Bioscience (Schol Ed) 3: 1032-1037.
3. Lupberger, J., M.B. Zeisel, F. Xiao, C. Thumann, I. Fofana, L. Zona, C. Davis, C.J. Mee, M. Turek, S. Gorke, C. Royer, B. Fischer, M.N. Zahid, D. Lavillette, J. Fresquet, F.L. Cosset, S.M. Rothenberg, T. Pietschmann, A.H. Patel, P. Pessaux, M. Doffoël, W. Raffelsberger, O. Poch, J.A. McKeating, L. Brino, and T.F. Baumert. 2011. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nature Medicine 17: 589-595.
4. Verma, S., and P.J. Thuluvath. 2007. Complementary and alternative medicine in hepatology: Review of the evidence of efficacy. Clinical Gastroenterology Hepatology 5: 408-416. (Pubitemid 46575355)
5. Hong, F., B. Jaruga, W.H. Kim, S. Radaeva, O.N. El-Assal, Z. Tian, V.A. Nguyen, and B. Gao. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: Regulation by SOCS. The Journal of Clinical Investigation 110: 1503-1513. (Pubitemid 35396921)
6. Tu, C.T., B. Han, H.C. Liu, and S.C. Zhang. 2011. Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression. Molecular and Cellular Biochemistry 358: 53-60.
7. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. The Journal of Clinical Investigation 90: 196-203.
8. Wang, H., O. Bloom, M. Zhang, J.M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama, and K.J. Tracey. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
9. Lotze, M.T., and K.J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nature Review Immunology 5: 331-542. (Pubitemid 40516158)
10. Erlandsson Harris, H., and U. Andersson. 2004. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. European Journal of Immunology 34: 1503-1512. (Pubitemid 39256031)
11. Sims, G.P., D.C. Rowe, S.T. Rietdijk, R. Herbst, and A.J. Coyle. 2010. HMGB1 and RAGE in inflammation and cancer. Annual Review Immunology 28: 367-388.
12. Andersson, U., and K.J. Tracey. 2011. HMGB1 is a therapeutic target for sterile inflammation and infection. Annual Review Immunology 29: 139-162.
13. Sass, G., S. Heinlein, A. Agli, R. Bang, J. Schümann, and G. Tiegs. 2002. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 19: 115-120. (Pubitemid 35216191)
14. Zhou, R.R., S.S. Zhao, M.X. Zou, P. Zhang, B.X. Zhang, X.H. Dai, N. Li, H.B. Liu, H. Wang, and X.G. Fan. 2011. HMGB1 cytoplasmic translocation in patients with acute liver failure. BMC Gastroenterology 11: 21.
15. Gong, Q., H. Zhang, J.H. Li, L.H. Duan, S. Zhong, X.L. Kong, F. Zheng, Z. Tan, P. Xiong, G. Chen, M. Fang, and F.L. Gong. 2010. High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice. Journal of Molecular Medicine 88: 1289-1298.
16. Takano, K., M. Shinoda, M. Tanabe, T. Miyasho, S. Yamada, S. Ono, Y. Masugi, K. Suda, K. Fukunaga, T. Hayashida, T. Hibi, H. Obara, H. Takeuchi, S. Kawachi, K. Kawasako, M. Okamoto, H. Yokota, I. Maruyama, and Y. Kitagawa. 2010. Protective effect of high-mobility group box 1 blockade on acute liver failure in rats. Shock 34: 573-579.
17. Tsung, A., R. Sahai, H. Tanaka, A. Nakao, M.P. Fink, M.T. Lotze, H. Yang, J. Li, K.J. Tracey, D.A. Geller, and T.R. Billiar. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. Journal of Experimental Medicine 201: 1135-1143. (Pubitemid 40524681)
18. Tsung, A., J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, X. Peng, D.B. Stolz, D.A. Geller, M.R. Rosengart, and T.R. Billiar. 2007. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. Journal of Experimental Medicine 204: 2913-2923. (Pubitemid 350179560)
19. Corson, T.W., and C.M. Crews. 2007. Molecular understanding and modern application of traditional medicines: Triumphs and trials. Cell 130: 769-774. (Pubitemid 47332575)
20. Aggarwal, B.B., and K.B. Harikumar. 2009. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemical Cell Biology 41: 40-59.
21. Tu, C.T., B. Han, Q.Y. Yao, Y.A. Zhang, H.C. Liu, and S.C. Zhang. 2012. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. International Immunopharmacology 12: 151-157.
22. Tang, D., R. Kang, H.J. Zeh 3rd, and M.T. Lotze. 2011. High-mobility group box 1, oxidative stress, and disease. Antioxidants & Redox Signaling 14: 1315-1335.
23. Kim, D.C., W. Lee, and J.S. Bae. 2011. Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflammation Research 60: 1161-1168.
24. Liu, A., O. Dirsch, H. Fang, W. Dong, H. Jin, H. Huang, J. Sun, and U. Dahmen. 2011. HMGB1 translocation and expression is caused by warm ischemia reperfusion injury, but not by partial hepatectomy in rats. Experimental and Molecular Pathology 91: 502-508.
25. Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
26. Ghosh, N., R. Ghosh, V. Mandal, and S.C. Mandal. 2011. Recent advances in herbal medicine for treatment of liver diseases. Pharmaceutical Biology 49: 970-988.
27. Lubbad, A., M.A. Oriowo, and I. Khan. 2009. Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis. Molecular and Cellular Biochemistry 322: 127-135.
28. Louis, H., O. Le Moine, M.O. Peny, E. Quertinmont, D. Fokan, M. Goldman, and J. Devière. 1997. Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice. Hepatology 25: 1382-1389. (Pubitemid 27250758)
29. Cardinal, J., P. Pan, R. Dhupar, M. Ross, A. Nakao, M. Lotze, T. Billiar, D. Geller, and A. Tsung. 2009. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology 50: 565-574.
30. Ogiku, M., H. Kono, M. Hara, M. Tsuchiya, and H. Fujii. 2011. Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats. Journal Pharmacology Experimental Therapeutics 339: 93-98.
31. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubartelli, A. Agresti, and M.E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. The EMBO Journal 22: 5551-5560. (Pubitemid 37279964)
32. Tang, D., R. Kang, K.M. Livesey, C.W. Cheh, A. Farkas, P. Loughran, G. Hoppe, M.E. Bianchi, K.J. Tracey, H.J. Zeh III, and M.T. Lotze. 2010. Endogenous HMGB1 regulates autophagy. The Journal of Cell Biology 190: 881-892.
33. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
34. Xu, J., X. Zhang, M. Monestier, N.L. Esmon, and C.T. Esmon. 2011. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. Journal of Immunology 187: 2626-2631.
35. Uesugi, T., M. Froh, G.E. Arteel, B.U. Bradford, and R.G. Thurman. 2001. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34: 101-108. (Pubitemid 32591488)